Microglia are the principle immune cells of the brain. Once activated, microglial cells may exhibit a wide repertoire of the context-dependent profiles ranging from highly neurotoxic to more protective and pro-regenerative cellular phenotypes. While to date the mechanisms involved in the molecular regulation of the microglia polarization phenotypes remain elusive, a growing evidence suggests that gender may markedly affect the inflammatory and/or glial responses following brain injuries. In the recent years, special attention has been given to the role of microglia in sexual dimorphism, both in healthy brain and diseased brain. Here, we review recent advances revealing microglia as an important determinant of gender differences under physiological conditions and in injured brain. We also discuss how microglia-driven innate immunity and signaling pathways might be involved in the sex -dependent responses following brain ischemic injury. Finally we describe how advanced methods such as live imaging techniques may help elucidate the role of microglia in the modulation of immune responses and gender difference after stroke.
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Introduction
Ischemic stroke is the third leading cause of death in western industrialized countries and a major cause of long-lasting disability (Barber et al., 2001; Dirnagl et al., 1999; Lo et al., 2003) . To date, in spite of intensive research efforts the clinical treatments remain poorly effective.
Growing evidence suggests that inflammation is a key element of the pathobiology of stroke, being involved in all stages of the ischemic cascade (Iadecola and Anrather, 2011; Kamel and Iadecola, 2012) . However, whether post-ischemic inflammatory response is detrimental and/or beneficial to injured neurons remains controversial. Microglial cells are the principal immune cells of the brain. While it has been widely established that microglial cells contribute to postischemic inflammation by producing TNF α, IL-1β, ROS species and other neurotoxic, proinflammatory molecules (Allan and Rothwell, 2001; Iadecola and Anrather, 2011) , they also contribute to resolution of inflammation and tissue repair by producing Il-4, IL-10, IGf-1, TGFbeta (Benakis et al., 2014; Iadecola and Anrather, 2011; Lalancette-Hebert et al., 2007; Lalancette-Hebert et al., 2012) . We and others have shown that activated microglia may directly exert neuroprotection by producing neutrophic molecules such as IGF-1 (Lalancette- Hebert et al., 2007; Lalancette-Hebert et al., 2012; O'Donnell et al., 2002) , BDNF (Miwa et al., 1997; Nakajima and Kohsaka, 2004) as well as other growth factors in a context-dependent fashion (Hanisch and Kettenmann, 2007) . Thus targeting inflammation and/or microglial activation profile towards neuroprotective phenotypes may appear as a valid strategy to limit brain damage after stroke. However, increasing evidence, in clinical and experimental stroke suggests that additional factors such as gender should be taken in consideration when deciphering the poststroke inflammatory cascade. Although microglial activation is a hallmark of the brain response to ischemic injury in male as well as in female brain, increasing evidence suggests a marked sexual dimorphism in the post-stroke inflammatory responses. It is now well established that gender has a substantial impact on the function of the nervous and immune systems. Namely, sex differences in glia number and function in the healthy and injured brain may give us important molecular cues on the mechanisms involved in sexual dimorphism during development and following the brain responses to injuries including stroke . In this brief review we will discuss the role of microglia as an important determinant of gender differences under physiological conditions and in the injured brain. We also will discuss how microglia-driven innate immunity and signaling pathways may contribute to the sex -dependent responses following brain ischemic injury in young brains and in the context of aging. Finally we will address how recent developments in imaging techniques as well as the cell-type specific molecular profiling approaches may help us elucidate the role of microglia in the modulation of immune responses and gender differences after stroke.
Microglia driven sexual dimorphism in healthy brain
Evidence suggests that microglia play an important role in the sexual differentiation of developing brain (Lenz and McCarthy, 2015) . Recent studies show that the number and phenotype of microglia differ in many regions of the female and male brain in rodents (Caplan et al., 2017) . Cortex, amygdala, hippocampus and preoptic area (POA) are some of the brain regions in which microglial gender dissimilarity has been reported (Lenz et al., 2013; McCarthy et al., 2015; Mouton et al., 2002; . In the developing POA, males have more amoeboid shaped microglia while females possess more surveying microglia , suggesting that the interaction between microglia and sex hormones plays a pivotal role during the development of the POA. For instance, Lenz et al. showed that brain sexual differentiation stems from the perinatal testicular androgen surge. In the POA, aromatase converts androgen to estrogen and consequently increases the expression of the microglia prostaglandin E2 (PGE2). The latter in turn increases the density of dendritic spines in males more than in females and masculinizes adult copulatory behavior. Furthermore, microglia inhibition by minocycline prevents the estradiol-induced upregulation of PGE2 and the subsequent events (Lenz et al., 2013) . These findings indicate that microglial activation patterns are important for gender-specific brain development. In keeping with these lines and, as suggested, by Nelson and colleagues (2017) microglia regulate brain development by modulating many physiological processes such as neurogenesis, cell survival and phagocytosis. For instance, neonatal female hippocampus shows significantly more microglia with phagocytic cups than the male hippocampus and female microglia phagocytize more neural progenitor cells. Of importance, treatment with estradiol, the hormone responsible for masculinization of the rodent brain, reduces the number of phagocytic microglia in females. Taken together, these results suggest that during different stages of the postnatal brain development gender is an important determinant of microglial morphology and function in the hippocampus as well as in other neuroanatomical regions of the brain (Nelson et al., 2017; ).
Importantly, the described postnatal sexual dimorphism persists in the adult brain As previously described, the expression patterns of microglia in the adult brain, the number and morphology of microglia are sexually dimorphic in different anatomical regions including POA, hippocampus, cortex and amygdala differ between males and females (Lenz et al., 2013; . These marked differences may lead to development of a distinct, sex-dependent microglia inflammatory responses in the brain. Indeed, sex differences in microglial activation patterns following brain injuries have been reported by different groups. Namely, Bodhankar et al. (2015) found that after MCAO, microglia from female mice had a milder inflammatory phenotype compared to males. Next, in several experimental stroke models, male mice show higher Iba-1-positive microglial density at lesion border (Acaz-Fonseca et al., 2015; Caplan et al., 2017) . In vitro, microglia separated from male and female brains demonstrate distinct inflammatory signatures to inflammatory insults such as LPS (Loram et al., 2012) . In vitro, male neonatal microglia show higher proinflammatory response to LPS and intriguingly estrogen has an antiinflammatory impact on male neonatal microglial cultures but proinflammatory effect on female cells (Caplan et al., 2017; Gunther et al., 2015; Loram et al., 2012) . Further confirming marked sex differences in microglial activation patterns are the recent reports from Bollinger et al. (2016) revealing differential effects of stress on microglial activation in female and male prefrontal cortex. Collectively, these observations suggest marked sex differences in the microglial activation patterns following injury and stress. Here it is noteworthy that the observed sex differences in the microglial activation patterns after stroke may trigger distinct downstream signaling cascades and thus have significant impact on the evolution of the ischemic brain injury.
In the next session we will review and discuss the molecular pathways involved in the sexdependent immune signaling following brain injuries.
Sex-specific signaling pathways contribute to inflammatory events following brain injury
As discussed above, a large body of evidence indicates that the brain response to ischemic injury is sexually dimorphic. However, whether the observed differences are exclusively hormonedependent and/or stem from distinct developmental mechanisms remains to be elucidates. The analyses of the downstream signaling events reveal that the molecular mechanisms underlying stroke-induced cell death and/or inflammation markedly differ in males and females. For example, caspases are mediators of cell death in females while the caspase-independent Poly (ADP-ribose) polymerase-1 (PARP-1) cell death and nitric oxide pathway predominate in males.
The loss of either PARP1 or nitric oxide synthase reduces infarct volume only in males (Manwani and McCullough, 2011; McCullough et al., 2005; Sohrabji et al., 2017) Since PARP-1 potentially modulates other neuroinflammatory conditions such as microglia responses to betaamyloid (Aβ) and experimental autoimmune encephalomyelitis (Kamboj et al., 2013; Kauppinen et al., 2011) , sex differences in these conditions are also conceivable. In addition to cell death mechanisms, it has been reported that stroke-induced activation of inflammatory and/or antiinflammatory signaling is sexually dimorphic. Examples include PPAR-α, PPAR-γ, High mobility group box 1 (HMGB1), IL-4 receptor and Insulin-like growth factor 1 (IGF-1) signaling pathways. PPAR-α and PPAR-γ activation has important roles in microglia polarization and inhibition of inflammatory signaling cascades by decreasing nuclear translocation of the NF-κB subunit p65 in neurons in experimental stroke and models of neurodegenerative diseases (Baek et al., 2015; Dehmer et al., 2004; Dotson et al., 2016) . Treatment with a PPAR-α agonist prior to stroke is only neuroprotective in males, probably because of the lower PPAR-α expression in the female brain (Dotson et al., 2016; Kadowaki et al., 2007) .
In addition to cell-death associated pathwhays, the sex differences have been also reported in the levels of many cytokines and chemokines . Recent evidence suggests that neuroprotective and anti-inflammatory cytokines such as IL-4 may transduce sex dependent signaling after stroke. Xiong et al. (2015) demonstrated that IL-4 is crucial for female neuroprotection during the estrus phase after ischemic stroke. IL-4 stimulates galectin-3 expression and release. Indeed, galectin-3 over-expression is a feature of alternative macrophage activation, triggering a positive feedback and thereby sustaining this phenotype . Secreted galectin-3 binds to-and cross-links CD98 on macrophages (MacKinnon et al., 2008) . Of relevance, IL-4 can directly induce the activation of PPAR-γ via IL-4 receptor dependent signaling pathways in addition to its effects on galectin-3 release (Huang et al., 1999) .
Our previous studies (males only) showed that galectin-3 is instrumental in ischemic injury induced microglia activation and proliferation (Lalancette-Hebert et al., 2012) . Notably, the defective microglia response in the galectin-3 deficient male mice was associated with larger infarctions and marked increase in the number of apoptotic neurons (Lalancette-Hebert et al., 2012) . Another interesting observation that came from the studies on galectin-3 deficient mice is a marked deregulation of innate immune response. Namely, the injury-induced TLR2 response was completely blunted in galectin-3 deficient male microglia, in vitro and in vivo (LalancetteHebert et al., 2012) . Interestingly however, our initial series of experiments performed on female mice suggest a tendency for smaller infarctions in galectin-3 deficient mice (unpublished evidence).
The sex-differences observed in TLR2 responses and IL4R/STAT6/PPAR-γ and/or IL4R/Galectin-3/PPAR-γ signaling after stroke are summarized in One of the potential downstream target of galectin-3 is IGF-1. This growth factor is a key molecule in galectin-3-induced microglia proliferation and alternative activation. IGF-1 decreases brain damage in different experimental settings, provokes neurogenesis and accelerates neuronal survival (Sohrabji and Williams, 2013) . Galectin-3 ablation leads to a marked deregulation of IGF-1 levels following ischemic injury which was associated with a deficit in microglial proliferation in response to IGF-1-mediated mitogenic signals (Lalancette-Hebert et al., 2012) . Sex dimorphism has been reported for IGF-1 regulatory mechanisms. Namely, IGF-1/ IGF-binding protein 3 ratio declines faster in males than in females (Waters et al., 2003) . Next, miRNAs such as Let7f (involved in the regulation of IGF-1) are also sexually dimorphic. In a rat model of ischemic stroke, intracerebroventricular administration of anti-Let7f, an antagomir against Let7f, is effective only in intact females but not in males or OVX females (Selvamani et al., 2012) . Taken together, described evidence strongly suggests the sex specific effects of IL-4/IGF-1/galectin-3 axis on the microglial phenotype and polarization after brain injuries.
Taken together sex differences in innate immunity have been reported in various experimental studies (Klein and Flanagan, 2016) . Intriguingly, estrogen and androgen response elements are located in the promoters of different innate immunity genes, suggesting that sex hormones might give rise to dimorphic innate immune responses in males and females (Hannah et al., 2008; Klein and Flanagan, 2016) .
Protective effects of estrogen in neuroinflammatory conditions
Most physiological and pharmacological actions of estrogen are mediated by binding to its specific receptors. Estrogen receptors (ERs) are classified into two different types; the first group constitutes the classical ERs, which belongs to the nuclear receptor superfamily (Hewitt et al., 2010) . The two ERs in this group are ERα and ERβ (Kuiper et al., 1996; Pérez-Álvarez and Wandosell, 2013) . In the presence of hormones, these receptors form homo and heterodimers, translocate to the nucleus and trigger transcription using either the estrogen response element sequences or other transcriptional proteins such as AP1 (Huang et al., 2010) . To date, many evidence suggests the importance of estrogen in regulation of CNS immune responses after brain damage and hypoxic conditions (Johann and Beyer, 2013) , however, there is ongoing debate regarding which of the two ERs, ERα or ERβ, mediates the beneficial effects in microglia (Wu et al., 2013) . Previous investigations indicate that ERα is responsible for the anti-inflammatory activity of estradiol in the brain (Vegeto et al., 2003) . At present, little is known about ERα-mediated signaling in microglia after brain ischemia. ERα can act as a ligand-activated transcription factor, but also possesses ligand-independent activities. By using a cell type specific ERα-mutant in an experimental model of stroke, Elzer et al. (2010) demonstrated that neuronal rather than microglial expression of ERα accounts for the neuroprotective effects of estrogen. On the other hand in a study conducted by Wu et al., it was shown that ERβ, rather than ERα, is preferentially expressed in microglia and that ERβ-selective agonists ameliorate experimental autoimmune encephalomyelitis by regulating both T cells and microglia (Wu et al., 2013) . , Finally, the results of our recent study (performed on menopaused/ageing female brains) suggest that ERα rather than ERβ mediates innate immune response and microglial activation following ischemia/reperfusion injury (Cordeau et al., 2016 ).
Her we may ask the question: Is therapy with estrogens protective after stroke? 17-beta-estradiol (17β-E2) is the most potent estrogen in circulation and has proven neuroprotective effects in different experimental models of cerebral ischemia (Manthey and Behl, 2006 have been also shown to mediate protective aspects of estrogen after ischemic insult. Estrogens are able to elicit rapid effects through GPR30 (Blasko et al., 2009) . GPR30 activation by either its endogenous ligand estrogen or specific agonist (G-1) potentiates pro-survival signaling pathways including epidermal growth factor receptor and PI3-kinase/Akt (Alexander et al., 2017) . Of note, gender specific effects have been reported with GPR30 in experimental stroke models. For instance, acute administration of GPR30 agonist alleviates hippocampal neuron loss in female rats after cerebral ischemia (Lebesgue et al., 2010) .
To date, it has been widely established that women are less vulnerable to stroke before menopause, while their estrogens levels are elevated. Namely, for a long time, the increased risk for stroke in women has been linked to the loss of sex hormones at the time of menopause. This notion has been used to model stroke in the rodents where ovariectomy (OVX) was shown to deteriorate brain damage (Manwani and McCullough, 2011) and exacerbate post-stroke inflammation (Cordeau et al., 2008 (Cordeau et al., , 2016 . Despite strong evidence supporting the protection by sex hormones in experimental models of brain ischemia, the results of clinical studies on the efficacy of estrogen therapy in female stroke patients were less conclusive (Hurn and Brass, 2003; Suzuki et al., 2009; Viscoli et al., 2001; Wise et al., 2001a; Wise et al., 2001b; Wise et al., 2001c) . While the neuroprotective and anti-inflammatory effects of estradiol have been demonstrated in experimental models of stroke, the hormone replacement therapy has been hindered by potential harmful events in humans, especially its association with endometrial and breast cancer as well as with the increased risk of thrombosis. Indeed the anti-inflammatory actions of estrogen on one cell type population do not necessarily mean that hormone replacement therapy is beneficial in controlled clinical trials. Many cell types in different tissues expression sex hormone receptors implying that estrogen therapy could elicit adverse reactions (Cummings et al., 2002; Tchaikovski and Rosing, 2010) . For example in some studies where the middle cerebral artery was permanently blocked, estrogen therapy in OVX female rats has been shown to aggravate ischemic injury (Bingham et al., 2005; Macrae and Carswell, 2006) . These experimental findings reveal both beneficial and detrimental effects of estrogen treatment on the stroke outcome. The route of administration, type of estrogen ligand used in the study, the experimental model of stroke and timing of estrogen treatment may all account for the observed discrepancies reported after estrogen-based therapies in stroke.
Does aging affects microglial activation patterns in a sex-dependent manner: lessons from
in vivo imaging studies Growing evidence suggests that aging is associated with the relative loss of immune homeostasis in resident microglia thus driving the development of more pro-inflammatory cellular phenotypes. Indeed, our imaging studies show that aging significantly increases the TLR2 responses following MCAO in both male and female mice. Moreover, an increase in the TLR2 signal was observed not only in response to ischemic injury but also in control, non-stroked animals (at the baseline levels), suggesting an-age dependent change in microglia resting profiles in male and female mice. As further shown in figure 2A -C, after MCAO aged males (15-17 months) have higher TLR2 expression in comparison to young adults (2-3 months), The same patterns of the TLR2 signals after MCAO were observed in the aged female mice revealing a higher levels of the TLR2 signals in comparison to young females (figure 2D-F).
As incidence of stroke increases with aging one of the major issues in the stroke pathobiology is the large increase in stroke burden among women after menopause. While women are protected when their estrogen levels are high, this protective gender effect is completely reversed after menopause with women being more vulnerable to stroke induced CNS damage than men.
Importantly, evidence suggests that, in addition to chronic estrogen deficiency, the process of aging in the female brain is associated with higher activation of the immune-related genes (Berchtold et al., 2008) . Of note, aging in female brain is associated with chronic deficiency in ER levels and with a marked decline in the expression levels of the functional ERα and/or increase in the expression of the ERα splice variants that act as dominant negative regulators of the ERα-mediated transcriptional activation and function Swaab, 2008, 2009 ).
How the lack of functional ERs and estrogen, as a complex paradigm of aging in the female brain may affects post-stroke inflammation and neuronal survival remains unclear. To address this issue we developed a model-system for live imaging of microglial activation in the context of chronic estrogen-and ERα-deficiency associated with aging. After stroke we observed a marked deregulation of the innate immune responses (TLR2 signals) and microglial activation in chronically OVX and ERα deficient mice (Cordeau et al., 2016) . ERα knockout mice expressed a significantly lower TLR2 response when compared to OVX mice (Cordeau et al., 2016) .
Furthermore, the loss of ERα was associated with a downregulation of galectin-3 and subsequent deregulation of microglial activation profile, including a robust induction of IL-6 and overactivation of the Janus kinase/STAT pathway. All these events led to significant increase of ischemia-induced brain damage. Taken together, these findings suggest that chronic estrogen deficiency together with a progressive loss of ERα function may account for increased vulnerability to stroke in aging females (Cordeau et al., 2016) . Here it is important to mention that the initial important differences in the innate immune responses observed in the model of female aging described above, were uncovered thanks to development of sensitive in vivo imaging model-systems we created for detection of inflammation from the brains of living animals.
Live imaging uncovers gender difference in glial responses following stroke
It is now feasible to visualize neuroinflammatory processes occurring in the brain in real-time as they evolve in time and space. Over the past years, we have developed and validated a series of mouse models, allowing the non-invasive and time-lapse imaging of processes associated with inflammation, neuronal damage and regeneration (Cordeau and Kriz, 2012; Cordeau et al., 2008; Gravel et al., 2011; Lalancette-Hebert et al., 2009 ). These in vivo imaging tools allowed us to visualize sexual dimorphism in the innate immune response/microglial activation patterns as well as in astrocyte responses following ischemic injury. As previously described (Cordeau et al., 2008) , using a reporter mouse, expressing luciferase gene under the transcriptional control of the murine glial fibrillary acidic protein (GFAP) promoter (GFAP-luc mice) revealed prominent effects of gender and estrogen on astrocyte response after ischemic injury. In fact, GFAP induction was significantly higher in female mice compared to males and this effect was highly dependent on the estrus cycle and serum estrogen level. As GFAP expression level correlates perfectly with a size of ischemic lesion in the male mice, the most important observation from this study is a complete absence of any correlation between GFAP signal and the size of ischemic lesion in female mice, thus suggesting that inflammatory response after stroke may be associated with a sex-specific biomarker of brain damage. These results are in agreement with the work from other groups describing marked sex-dependent differences in the astrocyte responses to injuries that were characterized by differentially regulated pro-inflammatory cytokines such as TNFα and IL-1β (Chisholm and Sohrabji, 2016; Loram et al., 2012; SantosGalindo et al., 2011) . Here it is important to mention that, unlike the functional differences obtained using a GFAP-luc mice, the sex differences obtained by imaging of the TLR2 signals (with exception of the female model of aging described previously) were mostly limited to the differences in the signal intensities, and in both sexes the intensity of the TLR2 signal correlated perfectly with the size of ischemic injury. Taken together, the development of novel imaging technologies such as bioluminescence imaging allows the real-time detection of subtle yet different aspects of microglia (and other glial cells such as astrocytes) involvement after stroke Lalancette-Hebert et al., 2017) .
Gender specific strategies should dictate the pharmacotherapy of stroke
Despite their promising results obtained in preclinical studies of stroke, several drug candidates are not successfully translated to the clinic. One major reason for this failure stems from a lack of gender specific experimental studies (Sohrabji et al., 2017) . As described in detail in the previous sections, the cell death pathways (PARP-1, NO and caspase), the cell survival pathways (IGF-1), innate immune responses and adaptive immunity are sexually dimorphic following brain ischemia. Namely, microglia from the stroked female mice have a lower inflammatory status than males and the percentage of CD4+ T lymphocytes is significantly higher in spleens of male stroked mice with higher expression of the activation markers such as CD69 and CD44. In contrast, the percentage of CD8+ T lymphocytes is significantly higher in spleens of females (Banerjee et al., 2013; Bodhankar et al., 2015) . Clinical studies demonstrate that thrombolytics have differential efficacy on stroke outcomes in males and females. Women show earlier improvement in response to tPA treatment (Kent et al., 2008) . Sex difference also exists in the response to anti-inflammatory agents and stem cell therapy. It has been shown in experimental and human stroke that the anti-inflammatory drug minocycline preferentially exert neuroprotection in male subjects (Amiri-Nikpour et al., 2015; Li and McCullough, 2009 ). Of note, Li and McCullough (2009) found that minocycline neuroprotective effects are mediated through inhibition of PARP-1 which is a male specific cell death pathway. Collectively, these studies strongly suggest important gender component in the post-stroke inflammatory response
SUMMARY AND FUTURE DIRECTIONS
A multitude of experimental and clinical studies reveal that microglia are sexually dimorphic in healthy and diseased brain. To develop gender specific strategies for pharmacotherapy of stroke we need to employ well-advanced technology to address heterogenic and context dependent properties of microglia in the complex settings like ischemic stroke. So far, the state of microglia activation has been oversimplified. Most studies classify activated microglia to either M1, the typically activated phenotype, or M2, an alternatively activated phenotype. According to this classification, M1 microglia are considered as proinflammatory, producing mediators such as TNF-ߙ, IL-1ߚ, and interferon-ߛ while M2 microglia contribute to recovery after damage and secrete anti-inflammatory mediators such as interleukin-IL-10, transforming growth factor-ߚ, IL-4, IL-13, and IGF-1 (Patel et al., 2013; Ransohoff, 2016) . This concept has been challenged (Ransohoff, 2016 ). An elegant study conducted by Morganti et al. (2016) demonstrated that following brain injury, microglia do not simply switch to a polarized "M1-only" or "M2-only" phenotype but rather display a mixed phenotype due to the complex signaling cascades surrounding them. Furthermore, single-cell RNA-seq researches on microglia uncover the existence of the mixed phenotype at the single-cell level (Kim et al., 2016) . To add to the complexity, our recent study revealed that following innate immune challenge activated microglia form completely diverging mRNA and protein networks, resulting in a distinct molecular signatures at mRNA and protein level (Boutej et al., 2017) . The next steps to explore sexual dimorphism in microglial responses after stroke might take advantage of single-cell RNAseq, proteomics and translating ribosome purification analyses. These methods may give us the unique opportunity to portray a more realistic picture on the important roles of microglia as one of the major determinants of sex difference following brain injury (Kumar et al., 2016; Ransohoff, 2016; Sun et al., 2015 , (Boutej et al., 2017 ).
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